Research Findings
Research Activities: Online Newsletter
Summarizes study findings, including those specific or relevant to drugs, pharmaceuticals, and therapeutics
Top of Page
Resources
Advancing Pharmacy Health Literacy Practices Through Quality Improvement: Curricular Modules for Faculty
Blood Thinner Pills: Using Them Safely
Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation
Outcomes of Pharmaceutical Outcomes Research—Impact of Studies Funded: Final Report
Outcomes of Pharmaceutical Therapy: Program Update
Pharmacy Health Literacy Center
Automated Telephone Reminders
How to Create a Pill Card
Is Our Pharmacy Meeting Patients' Needs? A Pharmacy Health Literacy Assessment Tool User's Guide
Strategies To Improve Communication Between Pharmacy Staff and Patients
Prescription Drug Therapies: Reducing Costs and Improving Outcomes
Quick Tips—When Getting a Prescription
Your Medicine: Be Smart. Be Safe. (en español)
Top of Page
Centers for Education and Research on Therapeutics (CERTs)
CERTs Web Site
CERTs Overview: Fact Sheet
Nominations of Topics for Research on Therapeutics
Preventable Adverse Drug Reactions: A Focus on Drug Interactions
Top of Page
Comparative Effectiveness Reviews
Comparative Effectiveness Review, No. 3:
Comparative Effectiveness of Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment
Comparative Effectiveness Review, No. 4:
Comparative Effectiveness and Safety of Analgesics for Osteoarthritis
Comparative Effectiveness Review, No. 6:
Efficacy and Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics
Comparative Effectiveness Review, No. 7:
Comparative Effectiveness of Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression
Comparative Effectiveness Review, No. 8:
Comparative Effectiveness and Safety of Oral Diabetes Medications for Adults With Type 2 Diabetes
Comparative Effectiveness Review, No. 10:
Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension
Comparative Effectiveness Review, No. 11:
Comparative Effectiveness of Drug Therapy for Rheumatoid Arthritis and Psoriatic Arthritis in Adults
Comparative Effectiveness Review, No. 51:
Dietary Supplements in Adults Taking Cardiovascular Drugs
Comparative Effectiveness Review, No. 55:
Drug Therapy for Rheumatoid Arthritis in Adults: An Update
Top of Page
Evidence Reports
Evidence Report/Technology Assessment, No. 196:
Assessment of Thiopurine Methyltransferase Activity in Patients Prescribed Azathioprine or Other Thiopurine-based Drugs
Top of Page
Medical Expenditure Panel Survey (MEPS) Reports
MEPS Chartbook, Number 16
Outpatient Prescription Drug Expenses in the U.S. Community Population, 2003 (PDF File, 397 KB; Plugin Software Help)
MEPS Research Findings, Number 25
Trends in the Pharmaceutical Treatment of Hypertension, 1997 to 2003 (PDF File, 1.6 MB; Plugin Software Help)
MEPS Statistical Brief, Number 58:
Chronic Conditions and Outpatient Prescription Medicines for Persons 18 and Older in the U.S. Civilian Noninstitutionalized Population, 1987 and 2001 (PDF File, 155 KB; Plugin Software Help)
MEPS Statistical Brief, Number 102:
Prescription Drugs: Out-of-Pocket Expenses and Unmet Need Relative to Family Income, 2002 (PDF File, 90 KB; Plugin Software Help)
MEPS Statistical Brief, Number 139:
Trends in the Use and Expenditures for COX-2 Inhibitors and Traditional Nonsteroidal Anti-inflammatory Drugs, 1997-2003 (PDF File, 105 KB; Plugin Software Help)
MEPS Statistical Brief, Number 144:
Trends in Brand Name and Generic Prescribed Medicine Utilization and Expenditures, 1999 and 2003 (PDF File, 85 KB; Plugin Software Help)
MEPS Statistical Brief, Number 154:
The Top Five Therapeutic Classes of Outpatient Prescription Drugs Ranked by Total Expense for Adults Age 18 and Older in the U.S. Civilian Noninstitutionalized Population, 2004 (PDF File, 98 KB; Plugin Software Help)
MEPS Statistical Brief, Number 158:
Prescription Drug Expenditures in the 10 Largest States for Persons under Age 65, 2004 (PDF File, 107 KB; Plugin Software Help)
MEPS Statistical Brief, Number 163:
Trends in the Use and Expenditures for the Therapeutic Class Prescribed Psychotherapeutic Agents and All Subclasses, 1997 and 2004 (PDF File, 106 KB; Plugin Software Help)
MEPS Statistical Brief, Number 179:
Aspirin Use among the Adult U.S. Noninstitutionalized Population, with and without Indicators of Heart Disease, 2005 (PDF File, 114 KB; Plugin Software Help)
MEPS Statistical Brief, Number 313:
Expenditures for the Top Five Classes of Outpatient Prescription Drugs, Adult ages 18 and Older, 2008
Top of Page